Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Barry

Showing results (171-180 of 420) with videos related to

Pageof 42
Sort By:
Diagnostic Microbiology and Infectious Disease|February 17, 1999
In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk testP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1991
Susceptibility of Haemophilus influenzae to clarithromycin alone and in combination with its 14-hydroxy metaboliteA L Barry, P C Fuchs, M A Pfaller
Antimicrobial Agents and Chemotherapy|August 4, 1998
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzaeA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|January 1, 1970
Synthetic medium for susceptibility testingP D Hoeprich, A L Barry, G D Fay
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Interpretative criteria and quality control parameters for telithromycin disc diffusion susceptibility testsA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centersP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 29, 1999
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility testsA L Barry, P C Fuchs, S D Brown
Journal of Clinical Microbiology|November 1, 1983
Quality control parameters for susceptibility tests with 30-micrograms netilmicin disksA L Barry, T L Gavan, R N Jones
Surgery|May 1, 1984
Preparation of amniotic membranes for surgical use with antibiotic solutionsW L Gannaway, A L Barry, J D Trelford
Journal of Clinical Microbiology|July 1, 1993
Levofloxacin disk potency and tentative interpretive criteria for susceptibility testsM A Pfaller, A L Barry, P C Fuchs
Pageof 42

Showing results (171-180 of 420) with videos related to

Sort By:
Pageof 42
Diagnostic Microbiology and Infectious Disease|February 17, 1999
In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk testP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1991
Susceptibility of Haemophilus influenzae to clarithromycin alone and in combination with its 14-hydroxy metaboliteA L Barry, P C Fuchs, M A Pfaller
Antimicrobial Agents and Chemotherapy|August 4, 1998
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzaeA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|January 1, 1970
Synthetic medium for susceptibility testingP D Hoeprich, A L Barry, G D Fay
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Interpretative criteria and quality control parameters for telithromycin disc diffusion susceptibility testsA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centersP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 29, 1999
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility testsA L Barry, P C Fuchs, S D Brown
Journal of Clinical Microbiology|November 1, 1983
Quality control parameters for susceptibility tests with 30-micrograms netilmicin disksA L Barry, T L Gavan, R N Jones
Surgery|May 1, 1984
Preparation of amniotic membranes for surgical use with antibiotic solutionsW L Gannaway, A L Barry, J D Trelford
Journal of Clinical Microbiology|July 1, 1993
Levofloxacin disk potency and tentative interpretive criteria for susceptibility testsM A Pfaller, A L Barry, P C Fuchs
Pageof 42